Bookmark

Add to MyYahoo RSS

Cytosar-U, Cytarabine News

News on Cytosar-U, Cytarabine (generic) continually updated from thousands of sources around the net.

Saturday Aug 23 | Seeking Alpha

With Cyclacel, The Waiting Is The Hardest Part

Cyclacel shares have weakened as investors have avoided riskier biotechs, and perhaps due to some worries about potential competitive drugs sponsored by larger companies in pharma/biotech.

Comment?

Related Topix: Healthcare Law, Law, Oncology, Medicine

Tue Aug 19, 2014

BioSpace

Celator Pharmaceuticals, Inc. Initiates Pharmacokinetic And...

Celator Pharmaceuticals, Inc. , a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that the first patient has been enrolled in a Phase 2 pharmacokinetic and pharmacodynamics study evaluating the effects of CPX-351 Liposome Injection on cardiac repolarization in adult patients with acute hematologic ... (more)

Comment?

Related Topix: Medicine, Pharmacology, Daunorubicin (generic), DaunoXome, Leukemia, Health, Food and Drug Administration

Wed Aug 13, 2014

Hispanic Business

Synta Reports Second Quarter Financial Results and Provides Corporate Update

"Since the beginning of this year, ganetespib has reached several important clinical milestones across studies and cancer types, including encouraging results from the GALAXY-1 and ENCHANT Phase 2 studies in lung and breast cancer, and graduation to the Phase 3 extension in the AML LI-1 trial," said .

Comment?

Related Topix: Medicine

Hispanic Business

New Nanoparticles Findings from University of Texas Described [Just...

However, acquired tumor cell resistance often limits its use." The news correspondents obtained a quote from the research from the , "Previously, we discovered that 4- -stearoyl gemcitabine solid lipid nanoparticles -GemC18-SLNs) can overcome multiple acquired gemcitabine resistance mechanisms, including RRM1 overexpression.

Comment?

Related Topix: Medicine

•••
•••
•••
•••
•••
•••
•••